Skip to main content
David Wada, MD, Dermatology, Rochester, MN, George E. Wahlen Department of Veterans Affairs Medical Center

DavidAWadaMD

Dermatology Rochester, MN

Dermatopathology

Physician

Dr. Wada is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wada's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2009 - 2012
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Dermatopathology, 2007 - 2008
  • University of Utah Health
    University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2003 - 2007
  • Saint Joseph Hospital
    Saint Joseph HospitalResidency, Internal Medicine, 2002 - 2005
  • University of Hawaii, John A. Burns School of Medicine
    University of Hawaii, John A. Burns School of MedicineClass of 2002

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 2004 - 2026
  • HI State Medical License
    HI State Medical License 2020 - 2026
  • AZ State Medical License
    AZ State Medical License 2019 - 2026
  • ID State Medical License
    ID State Medical License 2015 - 2024
  • MN State Medical License
    MN State Medical License 2007 - 2012
  • CO State Medical License
    CO State Medical License 2002 - 2005
  • American Board of Dermatology Dermatology
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Dermatopathology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Desmoplastic Melanoma Responds to PD-1 Blockade Immunotherapy
    Desmoplastic Melanoma Responds to PD-1 Blockade ImmunotherapyMay 26th, 2022

Professional Memberships

Hospital Affiliations